Atul Saran

Insider Reports History

Location
Monrovia, CA
Signature
/s/ Jennifer Lynn Fox, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Sponsored

Holdings reported by Atul Saran:

Company Role Class Num Shares Value Price $ Report Date Ownership
Emergent BioSolutions Inc. EVP, Chief Strat & Dev Officer Common Stock 86,645 $157,694 $1.82 28 Feb 2023 Direct

Insider Reports Filed by Atul Saran

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EBS Emergent BioSolutions Inc. 28 Feb 2023 1 -$12,021 4 EVP, Chief Strat & Dev Officer 02 Mar 2023, 13:43
EBS Emergent BioSolutions Inc. 23 Feb 2023 2 -$16,804 4 EVP, Chief Strat & Dev Officer 27 Feb 2023, 19:23
EBS Emergent BioSolutions Inc. 08 Feb 2023 2 -$27,176 4 EVP, Chief Strat & Dev Officer 10 Feb 2023, 19:35
EBS Emergent BioSolutions Inc. 28 Feb 2022 4 +$1,569,631 4 EVP, Chief Strat & Dev Officer 02 Mar 2022, 17:45
EBS Emergent BioSolutions Inc. 23 Feb 2022 2 -$55,062 4 EVP, Corp Dev, GC & Secretary 25 Feb 2022, 16:19
EBS Emergent BioSolutions Inc. 22 Feb 2022 2 -$88,007 4 EVP, Corp Dev, GC & Secretary 24 Feb 2022, 17:51